期刊文献+

MRI在中晚期宫颈癌分期诊断中的价值 被引量:8

The Value of Magnetic Resonance Imaging in Clinical Stage of Mid-advanced Cervical Cancer
暂未订购
导出
摘要 目的:探讨磁共振成像技术(MRI)对宫颈癌临床分期的价值。方法:选择31例病理确诊为宫颈癌的中晚期患者在治疗前进行MRI检查,对其MRI成像特点进行分析记录,参照FIGO制订的标准,将临床妇检形成的分期和MRI盲法判定形成的分期分别与手术病理所见进行对比。结果:MRI对宫旁浸润的判断符合率为87%,敏感度为86%,特异度为88%,阳性预测值为86%,阴性预测值为88%,总的分期准确率为84%;对淋巴结转移预测的符合率为84%,敏感度为75%,特异度为87%,而临床妇检对宫旁浸润的判断符合率为81%,敏感度为79%,特异度为82%,阳性预测值为79%,阴性预测值为82%,总的分期准确率为71%。结论:①MRI对中晚期宫颈癌分期较临床妇检分期有较高的准确率,对判断宫旁浸润有着较高的符合率、敏感度和特异度。②在预测淋巴结转移方面,MRI有较高的符合率、敏感度和特异度,弥补了临床妇检的不足。③引入磁共振成像技术使宫颈癌分期有了更加可靠的客观依据,避免发生临床分期上过低或过高的判断,有利于选择、制定合理的治疗计划。 Objective: To evaluate the value of MRI in clinical stage of pretherapy cervical cancer. Methods:Thirty-one patients confirmed with cervical cancer whose tumor stage ranging from Ⅱ A to ⅣA undertook MRI and clinical physical examination 3-7 days prior to surgery. The imaging character were analyzed and recorded,according to FIGO standard, worked out and compared the difference between two methods. Results: MR had an accuracy of 84% in determining clinical stage of the disease,in distinguishing parametrical extension, the coincidence, sensitivity and specificity were 87 %, 86 %, and 88 % respectively, its positive and negative predictive value were 86 % and 88 %. In determining pelvic lymph node metastasis, The coincidence, sensitivity and specificity were 84% ,75% ,and 87% respectively. While clinical examination only had an accuracy of 71% in determining clinical stage of cervical cancer, the coincidence, sensitivity and specificity in differentiating parametrical extension were 81%, 79% and 82%, and its positive and negative predictive value were 79% and 82%. Conclusion: ① Compared MRI with clinical physical examination,the former is more accurate in determining stage of the disease and has a higher coincidence, sensitivity and specificity in differentiating parametrical extension. ②In determining pelvic lymph node metastasis,MR has a high coincidence,sensitivity and specificity which make up for the drawback of clinical physical examination. ③we have a reliable roof which help us avoid high or low evaluation in determining clinical stage of the cervical cancer by MRI. MRI is beneficial for us to select proper treatment for patients with cervical cancer.
出处 《实用临床医学(江西)》 CAS 2007年第10期108-111,共4页 Practical Clinical Medicine
基金 江西省卫生厅基金资助项目(050088)
关键词 磁共振成像 宫颈癌 肿瘤分期 magnetic resonance imaging cervical carcinoma tumor stage
  • 相关文献

参考文献9

  • 1Ozsarlak O, Tjalma W, Schepens E, et al. The Correlation of Preoperative CT, MR Imaging, and Clinical Staging (FIGO) with Histopathology Findings in Primary Cervical Carcinoma [J]. Eur Radiol, 2003,13(10) : 2338-2345.
  • 2章文华,吴令英.关于子宫颈癌综合治疗的商榷[J].中华肿瘤杂志,2003,25(2):206-208. 被引量:57
  • 3Kaur H, Silverman P M, Lyer R B, et al. Diagnosis, Staging,and Surveillance of Cervical Carcinoma[J]. AJR Am J Roentgenol, 2003,180(6) : 1621-1631.
  • 4江新青,谢琦,夏建东,梁长虹,彭国晖,刘璋,张静,叶伟军,梁志伟,郑力强,钟卫红,陈明旺.宫颈癌的MRI分析[J].中国医学影像技术,2003,19(3):351-353. 被引量:7
  • 5曹泽毅.妇科常见恶性肿瘤诊断与治疗规范[M].北京:人民卫生出版社,2002:30-45.
  • 6纪燕琴,黄凤英.新辅助介入化疗对巨块型子宫颈癌的疗效观察[J].肿瘤研究与临床,2006,18(12):824-826. 被引量:9
  • 7Srisomboon J, Tangchaitrong C A, Bhusawang Y, et al. Evaluation of Colposcopic Accuracy in Diagonosis of Cervical Neoplasia[J]. J Med Assoc Thai, 1996,79:423-428.
  • 8李立明.临床流行病学[M].北京:人民卫生出版社,2002:98-119.
  • 9Bipat S, Glas A S, Van der Velden J, et al. Computed Tomography and Magnetic Resonance Imaging in Staging of Uterine Cervical Carcinoma: a Systematic Review [J].Gynecol Oncol, 2003,91(1):59-66.

二级参考文献21

  • 1陈亦乐,贺国强,王尔东.髂内动脉灌注新辅助化疗在子宫颈癌治疗中的价值[J].中华妇产科杂志,2005,40(4):231-234. 被引量:46
  • 2谭道彩.子宫颈癌Ⅲb期化疗加镭疗的十年疗效[A]..见:第4次全国宫颈癌学术交流会论文摘要汇编[C].,1990.17-18.
  • 3Goff BA, Muntz HG, Paley PJ, et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol, 1999,74:436-442.
  • 4Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ⅰb carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol,1999,73:177-183.
  • 5Sardi JE, Girroli A, Sananes C, et al. Long-term follow up of the first randomized trial using neoadjuvant chemotherapy in stage Ⅰ b squamous carcinoma of the cervix: the final results. Gynecol Oncol, 1997,67:61-69.
  • 6Lin JC, Ho ES, Jan JS, et al. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 1996,61:101-108.
  • 7Sugiyama T, Nishida T, Hasuo Y, et al. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and /or radiotherapy for locally advanced cervical cancer. Gynecol Oncol, 1998,69:130-136.
  • 8Lahousen M, Haas J, Pickel H, et al. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial. Gynecol Oncology, 1999, 73: 196-201.
  • 9Tattersall MH, Ramirez C, Coppleson M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ⅰb-Ⅱa cervical cancer carcinoma of patients with pelvic lymph node metastases. Gynecol Oncol,1992,46:176-181.
  • 10Thomas G, Dembo A, Ackerman I, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol, 1998,69:137-145.

共引文献73

同被引文献59

引证文献8

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部